Sonova Holding AG stock analysis
Want to see SONVY full AI Analyst Report?
Sonova Holding AG (SONVY) Stock Price & Analysis
SONVY Stock Chart & Stats
- Day’s Range
- $68.55 - $68.55
- 52-Week Range
- $42.66 - $71.75
- Previous Close
- $68.83
- Volume
- N/A
- Average Volume (3M)
- 2,253
- Market Cap
- $19.69B
- Enterprise Value
- $19.25B
- Total Cash (Recent Filing)
- $672.15M
- Total Debt (Recent Filing)
- $1.74B
- Price to Earnings (P/E)
- 34.7
- Beta
- 0.87
- Next Earnings
- May 18, 2027 (Est.)
- EPS Estimate
- 1.54
- Last Dividend Ex-Date
- Jun 22, 2026
- Dividend Yield
- 1.69%
Bulls Say, Bears Say
Bulls Say
Sustained Market-share Gains
Repeated wholesale growth and 11 consecutive quarters of share gains indicate improving competitive position rather than a single launch benefit. A larger installed and channel footprint can support future fittings, upgrades, recurring accessories, and stronger negotiating leverage.
High Profitability And Strong Cash Conversion
Very high gross margins, expanding operating margins, and strong free-cash-flow conversion give Sonova resources to fund innovation, retail expansion, acquisitions, and transformation. This combination also provides resilience while supporting reinvestment in long-term growth.
Product Innovation And Retail Expansion
Positive early adoption of EON and continued retail expansion strengthen Sonova's direct customer access and product ecosystem. Combining innovation with owned or affiliated clinics can improve consumer conversion, aftercare engagement, and recurring upgrade opportunities over time.
Bears Say
Cochlear Implant Weakness And Regulatory Uncertainty
The cochlear implant segment is currently reducing growth and earnings support, with lower systems and upgrades compounded by China VBP effects. Uncertain U.S. approval timing for Integro could prolong the weakness and delay a recovery in this business.
Choppy Growth And Margin Pressure
Despite strong absolute profitability, recent revenue contraction and multi-year net-margin compression show that earnings momentum has not been consistently durable. Continued pressure could limit internal funding capacity and make future growth more dependent on execution and investment.
Sales And Marketing Efficiency Remains Unresolved
Sales and marketing spending grew 7.8% while management acknowledged that efficiency and conversion still need improvement. If higher commercial investment does not translate into proportionate customer acquisition and fittings, operating leverage and returns could remain constrained.
Sonova Holding AG News
SONVY FAQ
What was Sonova Holding AG’s price range in the past 12 months?
What is Sonova Holding AG’s market cap?
When is Sonova Holding AG’s upcoming earnings report date?
How were Sonova Holding AG’s earnings last quarter?
Is Sonova Holding AG overvalued?
Does Sonova Holding AG pay dividends?
What is Sonova Holding AG’s EPS estimate?
How many shares outstanding does Sonova Holding AG have?
What happened to Sonova Holding AG’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Sonova Holding AG?
What is the TipRanks Smart Score and how is it calculated?
Sonova Holding AG Stock Smart Score
Company Description
Sonova Holding AG
Headquartered in Stäfa, Switzerland, Sonova Holding AG is a leading provider of innovative hearing care solutions for both adults and children. The company's operations are divided into two primary segments: Hearing Instruments and Cochlear Implants. Sonova's extensive offerings include advanced wireless communication devices, rechargeable hearing aids, wireless headsets, speech-enhanced hearables, premium audiophile headphones, microphones, and wireless transmission systems, alongside comprehensive audiological care services. Its renowned hearing aid brands comprise Phonak, Unitron, and Hansaton, while Advanced Bionics is its flagship for cochlear implants. For consumer audio, Sonova offers products under the Sennheiser brand. The company delivers its audiological care through a vast network of around 3,600 clinics and stores operating under various regional names such as AudioNova, Audium, and Boots Hearingcare, among others. Additionally, its products are distributed via independent partners. Sonova boasts a significant international presence, serving markets across the United States, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1947, the company was formerly known as Phonak Holding AG before officially changing its name to Sonova Holding AG in August 2007.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Eric Alain Bernard
- Employees
- 18,447
- Website
- www.sonova.com
- Address
- Laubisrutistrasse 28, Stäfa, ZH, 8712, CH
Sonova Holding AG (SONVY) Earnings & Revenues
SONVY Company Deck
SONVY Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Sonova reported broad-based sales growth, continued market share gains, significant core EBIT and cash-flow growth, improved returns, strong early product reception and higher full-year guidance. The main challenges were the 10% decline in cochlear implant sales, uncertain U.S. regulatory timing for Integro, slower U.S. and Canadian retail performance, efficiency concerns around sales and marketing spending, discontinued-operation impairment charges and expected market moderation after launch-related stocking. Management nevertheless expressed confidence in continued share gains and execution in the second half.
View all SONVY earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 6 | 2 |
| Technical Analysis | 4 | 6 | 0 |
| Moving Averages | 10 | 0 | 2 |













